openPR Logo
Press release

Specialty Pharmaceutical Market to Witness Huge Growth by 2028 | Pfizer, Roche, Amgen, AbbVie, Novo Nordisk, Johnson & Johnson

10-08-2022 01:09 PM CET | Health & Medicine

Press release from: ReportsnReports

This Specialty Pharmaceutical Market report provides market segmentation in the most-detailed pattern. A high-level market analysis of major segments has been performed in the report and opportunities are identified. The market report not only deals with major industrial categories but also different associated segments such as services, technologies, & applications. What is more, the global Specialty Pharmaceutical Market research report provides market data in such a way that it also considers new product development from beginning to launch.

Click Here For a Free Sample + Related Graphs of the Report at: https://www.reportsnreports.com/contacts/requestsample.aspx?name=5905803

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
- Antibody
- Hormone
- Growth Factors
- Other

Segment by Application
- Tumor
- Diabetes
- Cardiovascular
- Hemophilia
- Other

By Region
- North America
- - the United States
- - Canada
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - India
- - Australia
- - China Taiwan
- - Indonesia
- - Thailand
- - Malaysia
- Latin America
- - Mexico
- - Brazil
- - Argentina
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - UAE

By Company
- Pfizer
- Roche
- Amgen
- AbbVie
- Novo Nordisk
- Johnson & Johnson
- Sanofi-Aventis
- Merck
- Eli Lilly
- Novartis
- 3sbio
- Changchun High Tech
- CP Guojian Pharmacy
- Biotech Pharma
- Gelgen Biopharma
- Innovent

Purchase This Report: https://www.reportsnreports.com/purchase.aspx?name=5905803

Table of Contents

1 Specialty Pharmaceutical Market Overview
1.1 Product Overview and Scope of Specialty Pharmaceutical
1.2 Specialty Pharmaceutical Segment by Type
1.2.1 Global Specialty Pharmaceutical Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Antibody
1.2.3 Hormone
1.2.4 Growth Factors
1.2.5 Other
1.3 Specialty Pharmaceutical Segment by Application
1.3.1 Global Specialty Pharmaceutical Sales Comparison by Application: (2022-2028)
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 Global Specialty Pharmaceutical Market Size Estimates and Forecasts
1.4.1 Global Specialty Pharmaceutical Revenue 2017-2028
1.4.2 Global Specialty Pharmaceutical Sales 2017-2028
1.4.3 Specialty Pharmaceutical Market Size by Region: 2017 Versus 2021 Versus 2028
2 Specialty Pharmaceutical Market Competition by Manufacturers
2.1 Global Specialty Pharmaceutical Sales Market Share by Manufacturers (2017-2022)
2.2 Global Specialty Pharmaceutical Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Specialty Pharmaceutical Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Specialty Pharmaceutical Manufacturing Sites, Area Served, Product Type
2.5 Specialty Pharmaceutical Market Competitive Situation and Trends
2.5.1 Specialty Pharmaceutical Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Specialty Pharmaceutical Players Market Share by Revenue
2.5.3 Global Specialty Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Specialty Pharmaceutical Retrospective Market Scenario by Region
3.1 Global Specialty Pharmaceutical Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Specialty Pharmaceutical Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Specialty Pharmaceutical Market Facts & Figures by Country
3.3.1 North America Specialty Pharmaceutical Sales by Country
3.3.2 North America Specialty Pharmaceutical Revenue by Country
3.3.3 the United States
3.3.4 Canada
3.4 Europe Specialty Pharmaceutical Market Facts & Figures by Country
3.4.1 Europe Specialty Pharmaceutical Sales by Country
3.4.2 Europe Specialty Pharmaceutical Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 UK
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Specialty Pharmaceutical Market Facts & Figures by Region
3.5.1 Asia Pacific Specialty Pharmaceutical Sales by Region
3.5.2 Asia Pacific Specialty Pharmaceutical Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Specialty Pharmaceutical Market Facts & Figures by Country
3.6.1 Latin America Specialty Pharmaceutical Sales by Country
3.6.2 Latin America Specialty Pharmaceutical Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Specialty Pharmaceutical Market Facts & Figures by Country
3.7.1 Middle East and Africa Specialty Pharmaceutical Sales by Country
3.7.2 Middle East and Africa Specialty Pharmaceutical Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Specialty Pharmaceutical Historic Market Analysis by Type
4.1 Global Specialty Pharmaceutical Sales Market Share by Type (2017-2022)
4.2 Global Specialty Pharmaceutical Revenue Market Share by Type (2017-2022)
4.3 Global Specialty Pharmaceutical Price by Type (2017-2022)
5 Global Specialty Pharmaceutical Historic Market Analysis by Application
5.1 Global Specialty Pharmaceutical Sales Market Share by Application (2017-2022)
5.2 Global Specialty Pharmaceutical Revenue Market Share by Application (2017-2022)
5.3 Global Specialty Pharmaceutical Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Pfizer Specialty Pharmaceutical Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Roche Specialty Pharmaceutical Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Amgen
6.3.1 Amgen Corporation Information
6.3.2 Amgen Description and Business Overview
6.3.3 Amgen Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Amgen Specialty Pharmaceutical Product Portfolio
6.3.5 Amgen Recent Developments/Updates
6.4 AbbVie
6.4.1 AbbVie Corporation Information
6.4.2 AbbVie Description and Business Overview
6.4.3 AbbVie Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.4.4 AbbVie Specialty Pharmaceutical Product Portfolio
6.4.5 AbbVie Recent Developments/Updates
6.5 Novo Nordisk
6.5.1 Novo Nordisk Corporation Information
6.5.2 Novo Nordisk Description and Business Overview
6.5.3 Novo Nordisk Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Novo Nordisk Specialty Pharmaceutical Product Portfolio
6.5.5 Novo Nordisk Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Johnson & Johnson Specialty Pharmaceutical Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Sanofi-Aventis
6.6.1 Sanofi-Aventis Corporation Information
6.6.2 Sanofi-Aventis Description and Business Overview
6.6.3 Sanofi-Aventis Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Sanofi-Aventis Specialty Pharmaceutical Product Portfolio
6.7.5 Sanofi-Aventis Recent Developments/Updates
6.8 Merck
6.8.1 Merck Corporation Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Merck Specialty Pharmaceutical Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 Eli Lilly
6.9.1 Eli Lilly Corporation Information
6.9.2 Eli Lilly Description and Business Overview
6.9.3 Eli Lilly Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Eli Lilly Specialty Pharmaceutical Product Portfolio
6.9.5 Eli Lilly Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Novartis Specialty Pharmaceutical Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 3sbio
6.11.1 3sbio Corporation Information
6.11.2 3sbio Specialty Pharmaceutical Description and Business Overview
6.11.3 3sbio Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.11.4 3sbio Specialty Pharmaceutical Product Portfolio
6.11.5 3sbio Recent Developments/Updates
6.12 Changchun High Tech
6.12.1 Changchun High Tech Corporation Information
6.12.2 Changchun High Tech Specialty Pharmaceutical Description and Business Overview
6.12.3 Changchun High Tech Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Changchun High Tech Specialty Pharmaceutical Product Portfolio
6.12.5 Changchun High Tech Recent Developments/Updates
6.13 CP Guojian Pharmacy
6.13.1 CP Guojian Pharmacy Corporation Information
6.13.2 CP Guojian Pharmacy Specialty Pharmaceutical Description and Business Overview
6.13.3 CP Guojian Pharmacy Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.13.4 CP Guojian Pharmacy Specialty Pharmaceutical Product Portfolio
6.13.5 CP Guojian Pharmacy Recent Developments/Updates
6.14 Biotech Pharma
6.14.1 Biotech Pharma Corporation Information
6.14.2 Biotech Pharma Specialty Pharmaceutical Description and Business Overview
6.14.3 Biotech Pharma Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Biotech Pharma Specialty Pharmaceutical Product Portfolio
6.14.5 Biotech Pharma Recent Developments/Updates
6.15 Gelgen Biopharma
6.15.1 Gelgen Biopharma Corporation Information
6.15.2 Gelgen Biopharma Specialty Pharmaceutical Description and Business Overview
6.15.3 Gelgen Biopharma Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Gelgen Biopharma Specialty Pharmaceutical Product Portfolio
6.15.5 Gelgen Biopharma Recent Developments/Updates
6.16 Innovent
6.16.1 Innovent Corporation Information
6.16.2 Innovent Specialty Pharmaceutical Description and Business Overview
6.16.3 Innovent Specialty Pharmaceutical Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Innovent Specialty Pharmaceutical Product Portfolio
6.16.5 Innovent Recent Developments/Updates
7 Specialty Pharmaceutical Manufacturing Cost Analysis
7.1 Specialty Pharmaceutical Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Specialty Pharmaceutical
7.4 Specialty Pharmaceutical Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Specialty Pharmaceutical Distributors List
8.3 Specialty Pharmaceutical Customers
9 Specialty Pharmaceutical Market Dynamics
9.1 Specialty Pharmaceutical Industry Trends
9.2 Specialty Pharmaceutical Market Drivers
9.3 Specialty Pharmaceutical Market Challenges
9.4 Specialty Pharmaceutical Market Restraints
10 Global Market Forecast

Contact Us:

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Specialty Pharmaceutical Market to Witness Huge Growth by 2028 | Pfizer, Roche, Amgen, AbbVie, Novo Nordisk, Johnson & Johnson here

News-ID: 2761369 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the